|
Originally published In Press as doi:10.1074/jbc.M304007200 on June 5, 2003
J. Biol. Chem., Vol. 278, Issue 35, 33200-33207, August 29, 2003
Human Rhinovirus 2 2Apro Recognition of Eukaryotic Initiation Factor 4GI
INVOLVEMENT OF AN EXOSITE*
Nicole Foeger ,
Eva M. Schmid and
Tim Skern
From the
Max F. Perutz Laboratories, University Departments at the Vienna
Biocenter, Department of Medical Biochemistry, Division of Biochemistry,
University of Vienna, Vienna Biocenter, Dr. Bohr-Gasse 9/3, A-1030 Vienna,
Austria
The 2A proteinase (2Apro) of human rhinovirus 2 is a cysteine
proteinase with a unique chymotrypsin-like fold. During viral replication,
2Apro performs self-processing by cleaving between its own N
terminus and the C terminus of the preceding protein, VP1. Subsequently,
2Apro cleaves the two isoforms of the cellular protein, eukaryotic
initiation factor (eIF) 4G. We have previously shown that HRV2
2Apro can directly bind to eIF4G isoforms. Here we demonstrate
using deletion mutants of eIF4GI that HRV2 2Apro requires eIF4GI
amino acids 600674 for binding; however, the amino acids at the
cleavage site, Arg681 Gly, are not required. The HRV2
2Apro binding domain for eIF4GI was identified by site-directed
mutagenesis. Specifically, mutations Leu17 Arg and
Asp35 Glu severely impaired HRV2 2Apro binding
and thus processing of eIF4GI in rabbit reticulocyte lysates; self-processing,
however, was not affected. Alanine scanning analysis further identified the
loop containing residues Tyr32, Ser33, and
Ser34 as important for eIF4GI binding. Although Asp35 is
part of the catalytic triad, most of the eIF4GI binding domain lies in a
unique exosite structure absent from other chymotrypsin-like enzymes and is
distinct from the substrate binding cleft. The exosite represents a novel
virulence determinant that may allow the development of specific inhibitors
for HRV2 2Apro.
Received for publication, April 16, 2003
, and in revised form, June 3, 2003.
* This work was supported by Grant P-16189 from the Austrian Science
Foundation (to T. S.). The costs of publication of this article were defrayed
in part by the payment of page charges. This article must therefore be hereby
marked "advertisement" in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
To whom correspondence should be addressed. Tel.: 43-1-4277-61620; Fax:
43-1-4277-9616; E-mail:
timothy.skern{at}univie.ac.at.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. J. Baxter, A. Roetzer, H.-D. Liebig, S. E. Sedelnikova, A. M. Hounslow, T. Skern, and J. P. Waltho
Structure and Dynamics of Coxsackievirus B4 2A Proteinase, an Enyzme Involved in the Etiology of Heart Disease
J. Virol.,
February 1, 2006;
80(3):
1451 - 1462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Inoue, S. Alexandersen, A. T. Clark, C. Murphy, M. Quan, S. M. Reid, Y. Sakoda, H. L. Johns, and G. J. Belsham
Importance of Arginine 20 of the Swine Vesicular Disease Virus 2A Protease for Activity and Virulence
J. Virol.,
January 1, 2005;
79(1):
428 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Samuilova, C. Krogerus, T. Poyry, and T. Hyypia
Specific Interaction between Human Parechovirus Nonstructural 2A Protein and Viral RNA
J. Biol. Chem.,
September 3, 2004;
279(36):
37822 - 37831.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|